NCT02679287View on ClinicalTrials.gov

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

CLC

The CLC will be deployed with different functionalities at different stages of the trial, resulting in variation in what the subject will be responsible for and what the system will drive.

Trial Locations (1)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Roche Diagnostic Ltd.

INDUSTRY

collaborator

TypeZero Technologies, LLC

INDUSTRY

collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

lead

University of Virginia

OTHER

NCT02679287 - Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control | Biotech Hunter | Biotech Hunter